Atlas Trials

Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults

Clinical trial NCT07703956 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07703956
Sponsor
Vigonvita Life Sciences
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2026-07-31
Primary completion
2027-10-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.